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Extracellular vesicles (EVs) represent an important mode of intercellular communication. Research in this field
has grown rapidly in the last few years, and there is a plethora of techniques for the isolation and
characterization of EVs, many of which are poorly standardized. EVs are heterogeneous in size, origin and
molecular constituents, with considerable overlap in size and phenotype between different populations of EVs.
Little is known about current practices for the isolation, purification and characterization of EVs. We report
here the first large, detailed survey of current worldwide practices for the isolation and characterization of EVs.
Conditioned cell culture media was the most widely used material (83%). Ultracentrifugation remains the most
commonly used isolation method (81%) with 59% of respondents use a combination of methods. Only 9% of
respondents used only 1 characterization method, with others using 2 or more methods. Sample volume, sample
type and downstream application all influenced the isolation and characterization techniques employed.
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E
xtracellular vesicles (EVs) are membrane-enclosed
vesicles that are released from all cell types into the
extracellular space. EVs represent an important
mode of intercellular communication and play key roles in
many physiological and pathological processes (1,2). Con-
sequently, research in this field has grown rapidly in the last
few years, and there has been a huge growth in the number
of techniques for the isolation and characterization of EVs,
many of which are poorly standardized. EVs are hetero-
geneous in size, origin and molecular constituents, with
considerable overlap in size and phenotype between differ-
ent populations of EVs (e.g. exosomes formed in multi-
vesicular endosomes and vesicles released directly from the
membrane such as microvesicles) (35). Pure isolations of
EVs from tissue culture supernatant and body fluids are
hampered by the presence of non-vesicular macromolecular
structures that are present in variable extent in different
(body)fluids. This makes comparison of data from different
studies difficult. Besides ‘‘standard’’ differential (ultra)cen-
trifugation, density gradients, polymer-based precipitation,
microfiltration and size-exclusion-based methods have been
developed for EV isolation. Importantly, these isolation
methods all impact the amount, type and purity of EVs
recovered (6). The International Society for Extracellular
Vesicles (ISEV) has attempted to address some of these
issues through the publication of position papers, EV RNA
analysis (7) and EV-based therapeutics (8), and the minimal
experimental requirements for definition of EVs and their
function (MISEV) (5). However, little is known about
current practices for the isolation, purification and char-
acterization of EVs. We report here the first large, detailed
survey of current worldwide practices for the study of EVs.
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Methods
An online questionnaire was drafted and distributed via
an emailed web link to the members of ISEV (Supplemen-
tary Table I) in October 2015. The questionnaire included
questions about the number of EV samples analysed per
month, starting material, starting volume, primary isolation
technique, additional purification methods, characteriza-
tion methods and downstream applications. Each question
had multiple choice answers and/or an open-ended free
text option, some with non-mutually exclusive answers.
All questions were mandatory and at least one response
was required for each question. All electronically completed
questionnaires were collected by ISEV and converted to
an Excel file. Data were expressed as percentages.
Results
One hundred and ninety-six responses were collected from
individual researchers in 30 countries belonging to 4
continents (Fig. 1). It was not possible to ascertain the
country of origin for 2 responders. Workload varied widely:
38% of respondents isolated B10 EV samples per month,
49% processed 1050 samples per month, 9% processed 50
100 samples per month and 4% processed over 100 samples
per month. A wide range of starting sample volumes was
also reported, with 23% using over 100 ml of starting
material, 27% using 20100 ml, 21% using 520 ml, 16%
using 15 ml and 13% starting with B1 ml of the material.
Starting material
The most widely used starting material was conditioned
cell culture media (83%), with 29% of researchers using
both serum-enriched and serum-free culture conditions,
33% using only serum-added media and 37% using ex-
clusively serum-free culture conditions. Several researchers
indicated that EV-depleted serum was used but, as the
questionnaire did not ask whether or how this depletion
was performed, it is not possible to draw conclusions about
the prevalence of this practice. Researchers using EVs for
in vivo functional assays were most likely to use serum-free
culture conditions (64%), while only 50% of those perform-
ing RNA analysis used serum-free culture conditions
(Supplementary Table II).
With respect to the isolation of EVs from biofluids,
plasma (47%), serum (22%), urine (14%), cerebral spinal
fluid (8%) and milk (5%) were the most common body
fluids analysed (Fig. 2a). Only 4 researchers analysed
EVs from non-mammalian sources (bacteria, n2;
Caenorhabditis elegans, n2; parasites, n1). Not
surprisingly, the nature of the starting material had a
major effect on the starting volume. Researchers using
only conditioned media typically used much larger volumes
than those using only complex biofluids (Fig. 2b). The
majority of the respondents (96%) reporting a typical
starting volume of 100 ml used conditioned cell culture
media, whereas all of those reporting a typical sample
volume of B1 ml studied complex biological/body fluids.
There was an obvious relationship between the starting
material and the laboratory workload. High-throughput
laboratories (50 samples per month) were more likely
to use serum-free culture media (72%) than laboratories
processing B50 samples per month (52%) and were more
likely to be working with plasma samples (76% vs. 44%).
Isolation methods
Ultracentrifugation (including differential centrifugation)
remains by far the most widely used primary isolation
method (81%) across all applications (Fig. 3), with this
figure rising to 85% for isolation of EVs from conditioned
cell culture media. Over half (59%) of the respondents
used a combination of isolation techniques. It was notable
that researchers using exclusively conditioned culture
media were least likely to use a combination of methods
(44%), while those analysing complex biological fluids
tended to use a combination of up to 6 methods for
isolation and purification of EVs (65%). Density gradient
centrifugation (20%), filtration (18%) and size-exclusion
chromatography (SEC, 15%) were relatively well-used
methods. This survey suggests that magnetic bead separa-
tion is rarely used for isolation of EVs from conditioned
media (3%) but is more frequently used for isolating
EVs from complex biological materials (13%), and this
figure increased to 28% where the starting sample volume
was B1 ml. Precipitation techniques were used by 14%
of respondents but only 1 researcher reported using
precipitation without further isolation/purification tech-
niques. Of the researchers using precipitation techniques,
84% went on to perform RNA analysis. Less commonly
used isolation techniques included field flow fractionation
(n2), fluorescence-activated cell sorting (FACS, n2),
high-throughput/high-pressure liquid chromatography
(FPLC/HPLC, n3) and affinity separation techniques
(non-magnetic bead n4). The most commonly used
additional clean-up/purification methods (Supplementary
Table IV) were washing by ultracentrifugation (64%),
density gradient centrifugation (27%) and liquid chroma-
tography techniques (20%). Liquid chromatographic
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Fig. 1. Respondents by country (%).
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methods were most commonly used by researchers per-
forming proteomic analysis (20%) and in vitro functional
testing (21%), while those performing proteomics were
most likely to use density gradient centrifugation for
EV purification (37%). By contrast, 37% of researchers
performing proteomic analysis relied upon ultracentrifu-
gation and an ultracentrifugation wash to prepare EV for
analyses. It was notable that the use of liquid chromato-
graphy for EV purification was lowest among researchers
performing in vivo functional analyses (9% vs. an average
of 20%).
The starting sample volume had a substantial effect on
the isolation techniques used. Ultracentrifugation was
used as the primary isolation step by 80% of respon-
dents, but only 64% of those with limited sample volume
(e.g. B1 ml) used ultracentrifugation, 48% used an
ultracentrifuge protocol with a washing step and only
4% employed density gradient centrifugation. Conversely,
28% of researchers using sample volumes of B1 ml used
magnetic bead separation techniques, compared with a
figure of 6% of researchers purifying EVs from larger
starting volumes. It was notable that high-throughput
laboratories (50 samples per month) were much less
likely to use precipitation techniques than laboratories
processing B50 samples a month (4% vs. 15%).
Characterization methods
The 3 most widely used techniques for EV characteriza-
tion were western blotting (74%), single-particle tracking
(SPT, 72%) and electron microscopy (60%) (Fig. 4).
Of the respondents who used SPT, 16 did not specify
a method. Of the remainder, 80% used nanoparticle
tracking analysis (NTA) (Nanosight or Zeta View), 18%
used tunable resistive pulse sensing (TRPS) (Izon qNano)
and 12% used dynamic light scattering (DLS) (various
manufacturers). Flow cytometry remains a popular
method for analysing EVs, with 41% of respondents
using this method. Direct flow cytometry was employed
by 61% of flow cytometry users, while 49% used flow
cytometry following bead capture, with only 10% using
both techniques. This division in technique seemed to be
dictated by the cytometer used. It is likely that direct flow
cytometry was largely performed by researchers inter-
ested in EVs larger than 200 nm in diameter or those with
access to cytometers with small particle detection cap-
ability (e.g. Becton Dickinson Influx; Apogee A50-Micro;
Beckman Coulter MoFlo Astrios and CytoFLEX; and
Amnis ImageStream), whereas flow cytometry following
bead capture was generally performed on more conven-
tional cytometers (e.g. FACSCalibur, LSRFortessa and
MACSQuant) using aldehyde/sulphate latex beads. Pro-
tein assays were performed by 35% of respondents, with
most using BCA/micro BCA or Bradford assays, with
a B5% using NanoDrop or Qubit measurements. The
use of protein assays was highest amongst researchers
performing proteomic analysis (41%) and lowest in those
conducting in vivo investigations (32%).
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Fig. 2. (a) Starting material used by respondents by percentage. (b) Starting volume by sample type.Only responses indicating a single
type of sample were included in the analysis (05 ml, n22; 5100 ml, n51; 100 ml, n28).
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Atomic force microscopy was used by 9% of researchers,
and several other techniques were used by a small
number of respondents: antibody microarrays (n5),
procoagulant assays (n5), non-flow-cytometric fluores-
cence methods (n4), Raman spectroscopy (n3),
ELISA (n2), acetylcholine/acetylcholinesterase activity
assays (n2), SP6800 spectral analyser (n1), capillary
electrophoresis (n1), HPLC analysis (n1), infrared
spectroscopy (n1) and zeta potential measurement
(n1). The number of methods used for EV characteriza-
tion varied widely. Nine percent of respondents reported
using only 1 characterization method, 23% used 2 meth-
ods, 33% 3 methods, 23% 4 methods and 12% used 5 or
more characterization methods.
Downstream applications
The most common downstream applications (Fig. 5) were
in vitro functional analyses (72%), RNA analysis (60%),
proteomic analysis (47%), in vivo functional analyses
(29%) and lipidomic analysis (5%). Investigation of EVs
as therapeutic agents was performed by 6 researchers,
6 stated that novel biomarker discovery was their main
application, 1 analysed EV cytokine/chemokine profiles
and another used protein misfolding cyclic amplification
for the detection of infectious prions. Detailed descriptions
of functional assays were not recorded as this was beyond
the scope of this survey. It was notable that while several
respondents used serum-containing conditioned media
for proteomic analysis, very few use serum-added media
without extensive isolation/purification techniques.
The combinations of tests used by researchers were
worthy of comment. Fifty-six percent of researchers
performing RNA analysis also performed proteomic
analysis, whereas 70% of those performing proteomics
went on to analyse RNA. Similarly, while only 38% of
researchers performing in vitro functional testing also
investigated in vivo function, almost all of those inves-
tigating in vivo function also performed in vitro func-
tional analysis (96%). High-throughput laboratories
(50 samples/month) were almost twice as likely to
perform in vivo functional analysis as other laboratories
(48% vs. 26%).
Discussion
Numerous methodologies have been used to isolate and
analyse EVs, and it is clear that the different techniques
influence the results of downstream analyses. We report on
the first world-wide survey on techniques currently used
for the isolation and characterization of EVs. At this time,
there is no consensus on a ‘‘gold standard’’ method for
EV isolation and purification (5). It is clear from the results
of this survey that the downstream application as well as
the type and volume of starting material have a major
influence on the selection of isolation method. As might be
expected, researchers dealing with complex biological
fluids and/or perform proteomic analysis tend to use
more elaborate isolation/purification strategies than those
who isolate EVs from conditioned cell culture media and/
or use flow cytometry for EV analysis.
Ultracentrifugation remains by far the most popular
primary isolation technique for EVs, irrespective of the
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Fig. 5. Downstream applications (%).
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starting material used. EVs isolated by ultracentrifugation
are known to suffer from non-vesicular macromolecule
contamination (9). This is clearly an issue for omics, RNA
and functional EV analysis (6). In this survey, the majority
of researchers isolating EVs by ultracentrifugation used an
additional purification/clean-up technique. Furthermore,
ultracentrifugation can cause aggregation of EVs (10,11),
which might lead to artifacts during flow cytometric
analysis and SPT analysis. Moreover, it has been reported
that aggregation may affect the biodistribution of EVs
in vivo (12,13). The application of SEC and other
chromatography techniques (e.g. HPLC) to EV isolation
was described in the early 1980s (14) but was re-evaluated
and validated only 2 years ago: since then, 15% of
respondents already reported using these techniques.
Although the purity of EVs isolated by these methods
depends upon both the starting material and separation
media used, it has been reported that EVs isolated
by chromatographic methods suffer less contamination
by non-vesicular proteins and macromolecule structures
than after ultracentrifugation (13,15,16). Lipoprotein
contamination had been identified as an important source
of interference in EVs isolated from blood. Low-density
lipoprotein contamination of blood-derived EVs interferes
with flow cytometric analysis and is not entirely eliminated
by ultracentrifugation (17). Co-isolation of high-density
lipoprotein with EVs isolated by density gradient centri-
fugation has also been reported (18), resulting in non-
vesicular miRNA contamination of EVs (19). It is possible
that different EV isolation methods may preferentially
isolate different EV populations, with different size,
protein, RNA and functional characteristics (6,13,20).
A considerable number of researchers (28%) used cell
culture media supplemented with serum as their starting
material. Serum is replete with EVs, which can influence
the growth and the phenotype of cultured cells, and
consequently, indirectly influence the quality and quantity
of EVs secreted by those cells (21). Additionally, EV-
depleted serum has reduced capacity to support cell
growth (22), which may also impact on the recovery of
EVs from conditioned media under these conditions.
Further, the serum EVs carry a different subset of RNAs,
proteins and lipids and can directly affect the experi-
mental results involving proteomics, RNA analysis and
functional analysis of the isolated EVs from the serum-
added culture-conditioned media, if serum-derived
EV depletion is not carried out efficiently. Conversely,
switching cells grown in serum-containing medium to
serum-free conditions during the EV-secretion time in-
duces stress, which also may affect the nature and amount
of secreted EVs.
To maintain quality and reproducibility in EV research,
it is important to consider the impact of added EVs from
serum to the culture media. Including EVs from a control cell
type grown under similar culture conditions, EV-depleted
bodyfluid/culture media, coupled with a transparent re-
porting of methods, may reveal EV-specific findings.
Collectively, this necessitates suitable standards for EV
isolation, characterization and analysis methods (5).
It was notable that most respondents reported that
they used 2 or more methods for EV characterization, as
recommended in MISEV (5). Single-particle analyses by
NTA, TRPS and DLS are now widely used techniques
for the quantification and sizing of EVs but currently do
not provide much information regarding phenotype and
are not ideal for measuring larger (200 nm) vesicles.
However, as most EVs released by living cells are B300 nm,
this is rarely a problem but it should be noted that
these methods perform poorly with EVs, which are highly
polydisperse. A few researchers are beginning to combine
these techniques with other methodologies, for example,
TRPS with Raman spectroscopy and NTA with fluores-
cence labelling, but these combinations may not be
commercially available for several years. Until recently,
flow cytometry could analyse only large EVs or popula-
tions of smaller EVs captured on beads prior to analysis.
This survey demonstrated the impact of next-generation
flow cytometers equipped with small particle detectors on
EV analysis, with several researchers performing direct
flow cytometry of EVs using these advanced cytometers.
However, proper validation of these analyses, especially
to confirm that single vesicles rather than swarms of EVs
are analysed, is not always easy to provide.
This survey had several limitations. As the survey
was sent to all ISEV members, on several occasions the
data included responses from more than 1 person from
the same department. However, the responses from
individuals within the same department frequently differed
with respect to the type of sample and techniques used.
Many respondents analysed several different types of
sample, and as some of the survey questions (e.g. starting
volume) allowed only a single response, it was not possible
to record different responses for different types of sample.
Several respondents stated that while they used large
volumes of conditioned media, much smaller volumes
of complex biological fluids (e.g. CSF and plasma) were
typically used. Similarly, it is highly unlikely that the
researchers who use many different techniques and appli-
cations use all techniques and applications on all sample
types.
This survey offers a snapshot of the techniques for EV
isolation and characterization used by ISEV members in
late 2015. It is clear that the techniques used in the field
are rapidly evolving, and this will create opportunities
for future EV research. The rapidly evolving landscape
will also pose challenges for future standardization. It is
anticipated that the data from this survey will influence
future ISEV position papers and that future surveys will
identify trends and evolving practices in EV research.
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